Based on the above findings, it is suggested that AZF may alleviate inflammation and immune responses in AD mice through downregulating the expression of Tnf and Il1b genes, thereby modulating the TNF and NF-κB immune signaling pathways. The gene discussed is IL1B; the disease is Alzheimer disease.